Radioactive seeds zaps tumors from the inside
NCT ID NCT03889899
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a device called DaRT that delivers alpha radiation directly into tumors. It is for people with certain skin cancers, mouth cancers, or soft tissue sarcomas that are up to 7 centimeters in size. The goal is to see if the tumors shrink and to check for side effects. About 30 participants will be enrolled.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Diffusing Alpha Radiation Emitters Therapy (DaRT) device
- What this could lead to
- If it works, this could offer a new, targeted radiation option for certain skin and soft tissue cancers that are hard to treat.
- What could go wrong
- This is an early study with only 30 people, so results may not apply to everyone. The treatment involves inserting radioactive seeds, which carries risks like infection or incomplete tumor response.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUCOSAL NEOPLASM OF ORAL CAVITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
RAMBAM Health Care Campus
RECRUITINGHaifa, 3109601, Israel
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can your genes predict your melanoma risk?
- A UV photo and a cheek swab may be the keys to stopping sunburn before it starts
- Night shift workers' skin may struggle to fix sun damage, study suggests
- What makes skin cancer patients happy after surgery?
- Alpha radiation seeds target tumors from the inside
- AI reads social media posts to spot suicide risk in skin cancer patients